aspsirna0263 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0263
siRNA Name: LRRK2 P15_16A
Gene:Leucine rich repeat kinase 2 (LRRK2) Gene
Disease:Parkinsons disease (PD)
Wild allele/target (5'->3'): CUACGGCAUUGCUCAGUAC
Mutant allele/target (5'->3'):CUAUAGCAUUGCUCAGUAC
Target Mutation: c.6055G>A,p.Gly2019Ser
Wild siRNA (As strand):GAUGCCGUAACGAGUCAUG
ASP-siRNA (As strand):GAUAUCGUAACGAGUCAUG
Mismatch position in siRNA: U15C,A16G
Mutant allele (5'->3'): CUAUAGCAUUGCUCAGUAC
ASP-siRNA (As strand):GAUAUCGUAACGAGUCAUG
ASP-siRNA efficacy for mutant allele:50
Wild allele (5'->3'): CUACGGCAUUGCUCAGUAC
ASP-siRNA (As strand):GAUAUCGUAACGAGUCAUG
ASP-siRNA efficacy for wild allele:21
Percentage discrimination for ASP-siRNA:29
Wild allele (5'->3'): CUACGGCAUUGCUCAGUAC
Wild siRNA (As strand):GAUGCCGUAACGAGUCAUG
Wild sirna efficacy for wild allele:High efficacy
Wild allele (5'->3'): CUACGGCAUUGCUCAGUAC
ASP-siRNA (As strand):GAUAUCGUAACGAGUCAUG
Wild sirna efficacy for mutant allele:Moderate efficacy
Percentage discrimination for wild siRNA:Poor discrimination
Concentration:50nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q5S007
Target sequence: UUGCAAAGAUUGCUGACUACGGCAUUGCUCAGUACUGC
Genbank Accesion: NM_198578.3
Cell-line: HEK293
Experimental technique used: Flourescence microscopy
Transfection method: Lipofectamine 2000
siRNA expression method: Sigma Genosys
Post-transfection duration: 48 hours
OMID ID: 168600
KEGG disease ID:H00057
Reference:22031823

.
.
.
.
.
.
.
.
.
.
.

.

.

.